DOXORUBICIN HYDROCHLORIDE (Hospira, Inc.)
Welcome to the PulseAid listing for the DOXORUBICIN HYDROCHLORIDE drug offered from Hospira, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | doxorubicin hydrochloride |
SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRA-ARTERIAL; INTRAVENOUS; INTRAVESICAL |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2016-04-18 |
END MARKETING DATE: | 2017-12-31 |
DOXORUBICIN HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | DOXORUBICIN HYDROCHLORIDE from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2016-04-18 |
END MARKETING DATE: | 2017-12-31 |
PRODUCT ID: | 0409-0124_21dea217-18e8-431a-8445-3b9d2871aed3 |
PRODUCT NDC: | 0409-0124 |
APPLICATION NUMBER: | |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: